A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

Summary

This is a Phase 2 study, involving a 12-week treatment period, designed to evaluate the effectiveness of investigational study drug ARRY-371797 (versus placebo) in treating ankylosing spondylitis, and to further evaluate the drug's safety. Approximately 130 patients from the US, Canada, Poland and Hungary will be enrolled in this study.

Timeline

Start

2008-12-16

Primary completion

2009-09-29

Completion

2009-09-29

Drugs

Indications